Phenixfin Corp (PFX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 5, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PFX SEC filings page.
This page shows Phenixfin Corp (PFX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
PhenixFIN’s dominant mechanic is a widening gap between reported earnings, cash generation, and increasingly liability-funded asset growth.
FY2025 net income fell from$18.6M to$4.2M while operating cash flow swung from$16.1M positive to-$67.3M negative. With interest expense also rising to$10.3M , the combination signals weaker earnings quality: accounting profit was not converting into cash as financing costs intensified.
Total assets increased from
FY2025 interest expense was 8.3x selling, general and administrative expense, making financing cost the dominant disclosed expense burden. The FY2023 pattern—net income of
Financial Health Signals
Phenixfin Corp does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Phenixfin Corp passes 2 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass.
For every $1 of reported earnings, Phenixfin Corp used $16.20 of operating cash (-$67.3M OCF vs $4.2M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Key Financial Metrics
Earnings & Revenue
Phenixfin Corp reported $4.2M in net income in Q3 2026. This represents an increase of 382.1% from the same quarter a year earlier. Against the prior quarter it is up 272.9%.
Phenixfin Corp earned $2.19 per diluted share (EPS) in Q3 2026. This represents an increase of 395.9% from the same quarter a year earlier. Against the prior quarter it is up 284.2%.
Not reported for Q3 2026.
Not reported for Q3 2026.
Cash & Balance Sheet
Phenixfin Corp held $2.2M in cash as of Q3 2026; long-term debt is not reported for that period.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Phenixfin Corp's ROE was 2.7% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 3.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.9 percentage points.
Not reported for Q3 2026.
Not reported for Q3 2026.
Not reported for Q3 2026.
Capital Allocation
Phenixfin Corp spent $31K on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is down 99.0%.
Not reported for Q3 2026.
Not reported for Q3 2026.
PFX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| SG&A Expenses | $355K-10.8% | $362K+17.8% | $360K+62.5% | N/A | $398K+75.6% | $308K-1.0% | $222K-31.8% | N/A |
| Interest Expense | $2.3M-12.8% | $2.3M-10.5% | $2.4M-4.5% | N/A | $2.7M+54.5% | $2.6M+64.6% | $2.5M+65.1% | N/A |
| Net Income | $4.2M+382.1% | $1.1M+226.4% | -$4.8M-293.6% | N/A | -$1.5M-157.4% | -$896K-116.7% | $2.5M-45.6% | N/A |
| EPS (Basic) | $2.19+395.9% | $0.57+229.5% | -$2.38-295.1% | $2.03-32.8% | -$0.74-157.4% | -$0.44-116.8% | $1.22-44.3% | $3.02-14.4% |
| EPS (Diluted) | $2.19+395.9% | $0.57+229.5% | -$2.38-295.1% | $2.03-32.8% | -$0.74-157.4% | -$0.44-116.8% | $1.22-44.3% | $3.02-14.4% |
| Diluted Shares (Avg) | 2M-4.2% | 2M-2.3% | 2M-0.9% | N/A | 2M-0.1% | 2M-1.4% | 2M-2.6% | N/A |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, Income Tax.
PFX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $309.9M+1.0% | $305.6M+1.6% | $307.4M-1.5% | $316.9M+4.7% | $306.8M+24.6% | $300.7M+21.4% | $311.9M+31.1% | $302.8M+26.3% |
| Cash & Equivalents | $2.2M-69.9% | $3.1M-64.4% | $3.4M-52.8% | $7.3M-89.2% | $7.3M-18.0% | $8.7M-54.5% | $7.2M-41.0% | $67.6M+1026.7% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0-100.0% | $0 | $0 | $0-100.0% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $152.0M+1.3% | $151.8M+7.1% | $151.6M+1.6% | $156.1M+9.6% | $150.1M+63.0% | $141.7M+51.7% | $149.2M+71.2% | $142.4M+53.2% |
| Total Equity | $157.9M+0.7% | $153.8M-3.3% | $155.8M-4.3% | $160.8M+0.3% | $156.7M+1.6% | $159.0M+3.1% | $162.8M+8.0% | $160.3M+9.3% |
| Retained Earnings | -$543.4M+0.7% | -$547.5M-0.3% | -$548.6M-1.2% | -$543.9M+0.1% | -$547.4M-1.7% | -$545.9M-1.4% | -$542.1M+0.3% | -$544.6M+0.6% |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt.
PFX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$694K+89.9% | $2.7M-69.2% | -$2.0M+96.9% | -$3.0M-134.1% | -$6.9M+17.4% | $8.8M-1.9% | -$66.3M-1081.1% | $8.7M+294.3% |
| Financing Cash Flow | -$203K-103.7% | -$3.0M+58.2% | -$1.8M-131.3% | $3.0M-94.0% | $5.5M+381.7% | -$7.3M-262.8% | $5.9M+1135.0% | $50.0M+12463.3% |
| Dividends Paid | N/A | N/A | N/A | $0 | $0 | N/A | N/A | $0 |
| Share Buybacks | $31K | $3.1M | $183K | $5K | N/A | N/A | N/A | $0-100.0% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow.
PFX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | 2.7%+3.6pp | 0.7%+1.3pp | -3.1%-4.6pp | N/A | -1.0%-2.6pp | -0.6%-4.0pp | 1.5%-1.5pp | N/A |
| Return on Assets | 1.4%+1.8pp | 0.4%+0.7pp | -1.6%-2.3pp | N/A | -0.5%-1.6pp | -0.3%-2.5pp | 0.8%-1.1pp | N/A |
| Debt-to-Equity | 0.960.0x | 0.99+0.1x | 0.97+0.1x | 0.97+0.1x | 0.96+0.4x | 0.89+0.3x | 0.92+0.3x | 0.89+0.3x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Current Ratio, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Phenixfin Corp PFX | FY2025 | N/A | $4.2M | N/A | $88.8M | — |
| Ofs Capital OFS | FY2025 | N/A | -$33.1M | N/A | $52.4M | — |
Where Phenixfin Corp Ranks
Frequently Asked Questions
Is Phenixfin Corp profitable?
Yes, Phenixfin Corp (PFX) reported a net income of $4.2M in fiscal year 2025.
What is Phenixfin Corp's return on equity (ROE)?
Phenixfin Corp (PFX) has a return on equity of 2.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Phenixfin Corp's operating cash flow?
Phenixfin Corp (PFX) recorded an outflow of $67.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Phenixfin Corp's total assets?
Phenixfin Corp (PFX) had $316.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Phenixfin Corp's debt-to-equity ratio?
Phenixfin Corp (PFX) had a debt-to-equity ratio of 0.97 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Phenixfin Corp's return on assets (ROA)?
Phenixfin Corp (PFX) had a return on assets of 1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Phenixfin Corp's P/E ratio?
Phenixfin Corp (PFX) trades at 21.4x earnings, its market capitalization divided by net income of $4.2M net income, FY2025. The market capitalization is $88.8M as of Sep 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Phenixfin Corp's price-to-sales ratio?
Phenixfin Corp (PFX) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $88.8M as of Sep 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Phenixfin Corp's Piotroski F-Score?
Phenixfin Corp (PFX) has a Piotroski F-Score of 2 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Phenixfin Corp's earnings high quality?
For every $1 of reported earnings, Phenixfin Corp (PFX) used $16.20 of operating cash (-$67.3M OCF vs $4.2M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.